Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients-Reference-Cited by-同舟云学术

Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients

Published:1991-05 Issue:5 Volume:14 Page:304-312
ISSN:0391-3988
Container-title:The International Journal of Artificial Organs
language:en
Short-container-title:The International Journal of Artificial Organs

Author:

Faradji A.¹,Bohbot A.¹²,Schmitt-Goguel M.¹²,Dumont S.³,Eischen A.²,Wiesel M.L.⁴,Stierle A.⁴,Follea G.⁴,Eber M.⁵,Bergerat J.P.¹²,Bartholeyns J.³,Poindron P.³,Witz J.P.¹⁶,Frost H.⁷,Oberling F.¹²

Affiliation:

1. Département d'Onco-Hématologie, CHU Hautepierre, Strasbourg - France

2. Institut d'Immuno-Hématologie, Hôpital Civil, Strasbourg - France

3. Département d'Immunologie-Immunopharmacologie, UER Pharmacie, Strasbourg - France

4. Centre Régional de Transfusion Sanguine, Strasbourg - France

5. Centre Anticancer eux Paul Strauss, Strasbourg - France

6. Service de Chirurgie Thoracique, Hôpital Civil, Strasbourg - France

7. Ciba-Geigy Limited, Basle - Switzerland

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering

Link

http://journals.sagepub.com/doi/pdf/10.1177/039139889101400511

Reference15 articles.

1. A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

2. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment;Molecular Therapy - Methods & Clinical Development;2020-03

2. Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use;Journal of Translational Medicine;2019-03-14

3. A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer;Journal of Translational Medicine;2018-07-16

4. Challenges of Scale-up of Cell Separation and Purification Techniques;Bioprocessing for Cell Based Therapies;2016-12-16

5. Monocyte and interferon based therapy for the treatment of ovarian cancer;Cytokine & Growth Factor Reviews;2016-06